Nektar Therapeutics (NKTR) Non Operating Income (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Non Operating Income came in at -$4.0 million in Q1 2026, down 120.07% year-on-year from $20.1 million in Q1 2025, and up 42.65% quarter-over-quarter from -$7.0 million in Q4 2025.
Nektar Therapeutics (NKTR) Non Operating Income (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Non Operating Income history runs 17 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 120.07% year-over-year to -$4.0 million in Q1 2026; TTM through Mar 2026 was -$17.6 million, a 21.91% decrease from a year earlier, with the FY2025 full-year figure at -$15.4 million, down 9.88% from the prior year.
- Non Operating Income rose to -$4.0 million in Q1 2026 per NKTR's latest filing, from -$7.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $26.3 million in Q1 2022 and bottomed at -$8.6 million in Q4 2023.
- The 5-year median for Non Operating Income is -$3.2 million (2025), against an average of -$2.0 million.
- Across the five-year window, Non Operating Income surged 295.01% in 2022 and plunged 346.14% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$4.1 million in 2022, then tumbled by 110.97% to -$8.6 million in 2023, then advanced by 14.55% to -$7.3 million in 2024, then grew by 4.21% to -$7.0 million in 2025, then surged by 42.65% to -$4.0 million in 2026.
- Per Business Quant, the three latest NKTR Non Operating Income figures stand at -$4.0 million (Q1 2026), -$7.0 million (Q4 2025), and -$3.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | -4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.04 Mn |
| Dec 31, 2025 | -7.04 Mn |
| Sep 30, 2025 | -3.35 Mn |
| Jun 30, 2025 | -3.17 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | -2.54 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -8.60 Mn |
| Sep 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | -570,000.00 |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | -4.08 Mn |
| Sep 30, 2022 | -4.90 Mn |
| Jun 30, 2022 | -6.13 Mn |
| Mar 31, 2022 | 26.29 Mn |
| Dec 31, 2021 | -32.74 Mn |
| Sep 30, 2021 | -16.00 Mn |
| Jun 30, 2021 | -14.96 Mn |